Aseptic Sampling Market Size (2023 - 2030)

The global Aseptic Sampling Market is expected to reach USD 470 million by 2030 from USD 262 million in 2022 with a CAGR of 12.0% during the forecast period.

Aseptic sampling is a process used to avoid contamination by the sampling method. The sampling process involves containers and sterile sampling implements and the technique is an important facet in an efficient microbial control program.

The aseptic sampling process is to collect enormous samples like cell culture, bio-organic substances to prevent contamination from the environment, and other air-borne particles to maintain the integrity of the component. Bags, bottles, sterile and compatible containers, and syringes are major components used in aseptic sampling. The sampling process consumes less time and is noteworthy safe. Throughout the process, aseptic samples are used to validate and support the observations.

MARKET DRIVERS

The factors driving the aseptic sampling market include growing demand for biopharmaceuticals and strict government rules to confirm drug safety and rising funds for supporting life-science research activities. The adoption of single-use aseptic sampling products is rising government support and growing outsourcing of bioproduction process and developing research and development infrastructure mount the market growth globally.

Different pharmaceutical and biopharmaceutical companies are increasingly adopting aseptic samples to minimize the threat of contamination and initiatives for the quality and safety of the product drives the market further.

MARKET RESTRAINS

The situations linked with extractables and leachables as the sampling products are made from processed plastic polymers hindering the aseptic sampling market growth. The sluggish execution of highly upgraded technologies in biopharmaceutical manufacturing along with waste disposal acts as a challenge towards the aseptic sampling market growth. The shortage of poor medical facilities and poor technical knowledge obstruct the market growth.

Segmentation Analysis

The Aseptic Sampling Market at the global level has been segmented and sub-segmented based on the following categories:

Aseptic Sampling Market - By Type

• Manual Aseptic Sampling
• Automated Aseptic Sampling

The manual aseptic sampling segment dominates the market as it is the traditional method used in pharma and biopharma companies and introducing single-use aseptic sampling systems help the manufacturers avoid cross-contamination and cost issues.

The automated aseptic sampling type segment witness’s quick growth in the aseptic sampling market in 2022 due to the quick adoption of automated sampling is connected to its higher efficacy, less workforce consumption, and cost-saving. The increase in automated aseptic sampling grow with a 13.0% rate and the arrival of COVID-19 vaccines and other drugs to cure other diseases requiring intensive care.

Aseptic Sampling Market - By Process

• Upstream
• Downstream

The upstream process segment is calculated to have the largest CAGR rate. The upstream process is the initial stage of any biotechnological procedure. It is important to use aseptic sampling at the contamination stage which drives the upstream process globally.

Aseptic Sampling Market - By End-User

• Biotechnology and Pharmaceutical Manufacturer
• Healthcare
• Food & Beverages
• Others

Based on the end-user, the biotechnology and pharmaceutical manufacturer segment dominated the aseptic sampling market in 2022. The segment attributes to mounting acceptance of aseptic sampling in emerging manufacturing services due to the benefits like less budget and simple execution process.

Regional Analysis

1. North America
2. Asia Pacific
3. Latin America
4. Europe
5. Middle East & Africa

Geographically, North America is scheduled to have an outstanding share in the aseptic sampling market owing to amplifying government support on producing and quality pharma and biotech products. The United States is dominating the region with a quick rate and higher share. In 2018, the biotechnology companies in the U.S has spent nearly 14.9% of the business expenditure on biotechnology, as per the Organization for Economic Co-operation and Development (OECD) Statistics in 2022. The Canadian biotechnology companies have spent only 3.6% of their expenditure. Scientific breakthrough aids the need for an aseptic sampling market in North America.

The European market for aseptic sampling is said to dominate the market globally. The accumulating government investments and the growing number of companies participating in the research and development activities spur the aseptic sampling market growth in the region. In 2016, the gross domestic expenditure spent on research and development (R&D) was 33.1 billion Euros, as per the Office for National Statistics. Governments across many European countries are supporting the pharma companies in launching new biopharmaceutical products boom the aseptic sampling market growth in the region.

In Asia-Pacific, the Aseptic sampling market is expected to grow with the largest CAGR rate during the foreseen period. The market growth in the region owes to rising support from the government, extending the biomanufacturing field, and advancing research and development infrastructure. In China and India, the research activities are intensifying, and the growing demand for advanced technological equipment and sampling techniques boosting the market growth in the region. Also, in countries like China, and Japan, the key players are investing hugely in the healthcare facilities driving the market growth forward.

Latin America to have quickest growth in the aseptic sampling market throughout the forecast period.

The Middle East & African aseptic sampling markets have a very low rate during the period. The market in the region is expected to have gainful growth over the forthcoming years.

Key Market Players

Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher Corporation (US), and Thermo Fisher Scientific (US), Saint-Gobain (France), GEA Group (Germany), Avantor, Inc. (US), QualiTru Sampling Systems (US), Keofitt (Denmark), GEMÜ Group (US), W. L. Gore & Associates (US), Flownamics Analytical Instruments, Inc. (US), Lonza (Switzerland), and Trace Analytics (US) are some major companies involved in the aseptic testing market.

Recent Market Developments in the global Aseptic Sampling Market

• On August 26, 2022, Thermo Fisher Scientific and ChromSword collaborated to launch an automated high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (HPLC) development method system allowing chromatographers to deliver strong and validated methods in less time and with high confidence.
• On May 08, 2022, a biopharmaceutical industry's leading partner, Sartorius Stedim Biotech unveiled the new SIMCA 16 software for multivariate data analytics and is available from its subsidiary Sartorius Stedim Data Analytics.
• On March 19, 2022, Sartorius launched BIOSTAR STR Generation 3 single-use bioreactor and BIOBRAIN automation platform designed to make biopharmaceutical development and production quicker, easier and safer.

COVID-19 Impact on Aseptic Sampling Market

Due to the emergence of the pandemic situation, several companies started focusing on developing efficient vaccines, biologics, and drugs to fight the disease helps if increasing the need for aseptic testing. In countries like Europe and Asia, the manufacture of necessary drugs is surging exclusively and countries across the globe are cantering to harden growing manufacturing capacity and the requirements on the quality of the pharma and biotech products stimulating the aseptic market growth.